Business Description
Harpoon Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US41358P2056
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.18 | |||||
Equity-to-Asset | 0.1 | |||||
Debt-to-Equity | 3.19 | |||||
Debt-to-EBITDA | -0.57 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -4.53 | |||||
Beneish M-Score | 1.12 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 53.6 | |||||
3-Year EBITDA Growth Rate | 8.9 | |||||
3-Year EPS without NRI Growth Rate | 7.3 | |||||
3-Year FCF Growth Rate | -109.2 | |||||
3-Year Book Growth Rate | -65.8 | |||||
Future 3-5Y Total Revenue Growth Rate | 2.19 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49.34 | |||||
9-Day RSI | 58.13 | |||||
14-Day RSI | 68.9 | |||||
6-1 Month Momentum % | 152.76 | |||||
12-1 Month Momentum % | 205.19 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.89 | |||||
Quick Ratio | 1.89 | |||||
Cash Ratio | 1.75 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.8 | |||||
Shareholder Yield % | -1.58 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -100.14 | |||||
Net Margin % | -81.67 | |||||
FCF Margin % | -186.89 | |||||
ROE % | -498.9 | |||||
ROA % | -43.72 | |||||
ROIC % | -102.56 | |||||
ROC (Joel Greenblatt) % | -186.95 | |||||
ROCE % | -88.39 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.3 | |||||
PB Ratio | 20.82 | |||||
Price-to-Tangible-Book | 20.8 | |||||
EV-to-EBIT | -17.38 | |||||
EV-to-EBITDA | -18.71 | |||||
EV-to-Revenue | 12.73 | |||||
EV-to-Forward-Revenue | 23.18 | |||||
EV-to-FCF | -6.85 | |||||
Earnings Yield (Greenblatt) % | -5.75 | |||||
FCF Yield % | -14.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Harpoon Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 34.709 | ||
EPS (TTM) (€) | -8.241 | ||
Beta | 0 | ||
Volatility % | 155.23 | ||
14-Day RSI | 68.9 | ||
14-Day ATR (€) | 0.144799 | ||
20-Day SMA (€) | 20.74 | ||
12-1 Month Momentum % | 205.19 | ||
52-Week Range (€) | 4.86 - 21.2 | ||
Shares Outstanding (Mil) | 21.4 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Harpoon Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Harpoon Therapeutics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Harpoon Therapeutics Inc Frequently Asked Questions
What is Harpoon Therapeutics Inc(FRA:5HTA)'s stock price today?
When is next earnings date of Harpoon Therapeutics Inc(FRA:5HTA)?
Does Harpoon Therapeutics Inc(FRA:5HTA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |